Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 26 February 2024 31 March 2025 31 March 2025 15521457 Dr Astrid Van Wilsem iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15521457 2024-02-25 15521457 2025-03-31 15521457 2024-02-26 2025-03-31 15521457 frs-core:CurrentFinancialInstruments 2025-03-31 15521457 frs-bus:PrivateLimitedCompanyLtd 2024-02-26 2025-03-31 15521457 frs-bus:FilletedAccounts 2024-02-26 2025-03-31 15521457 frs-bus:Micro-entities 2024-02-26 2025-03-31 15521457 frs-bus:AuditExempt-NoAccountantsReport 2024-02-26 2025-03-31 15521457 frs-bus:Director1 2024-02-26 2025-03-31
Registered number: 15521457
Clinical Expertise And Support Ltd
Unaudited Financial Statements
For the Period 26 February 2024 to 31 March 2025
TaxAssist Accountants (Loughborough) Ltd
FMAAT
95 Ashby Road
Loughborough
Leicestershire
LE11 3AB
Balance Sheet
Registered number: 15521457
31 March 2025
£
Fixed assets 1,689
Current assets 41,291
Creditors: Amounts Falling Due Within One Year (11,487 )
NET CURRENT ASSETS 29,804
TOTAL ASSETS LESS CURRENT LIABILITIES 31,493
Accruals and deferred income (24,500 )
NET ASSETS 6,993
CAPITAL AND RESERVES 6,993

Notes

1. General Information
Clinical Expertise And Support Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15521457 . The registered office is 68 Sandalwood Road, Loughborough, LE11 3PS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Astrid Van Wilsem
Director
11 July 2025